Mereo Biopharma Group
We are a multi-asset biopharmaceutical company focused on the acquisition, development, and commercialization of innovative therapeutics that aim to improve outcomes for patients with rare and specialty diseases.
$17.62 - $17.62
Cowen, BMO Capital Markets, RBC Capital Markets, JMP Securities, Cantor Fitzgerald Europe
To view the prospectus for Mereo Biopharma Group IPO, or any offering listed on ClickIPO,
download the ClickIPO app...
or a prospectus can be requested from G. Price at
ClickIPO Securities, LLC 8601 N Scottsdale Rd, Suite 335, Scottsdale, AZ 85253